表紙:人工腎臓の世界市場2023-2030
市場調査レポート
商品コード
1292924

人工腎臓の世界市場2023-2030

Global Artificial Kidney Market 2023-2030


出版日
ページ情報
英文 145 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
人工腎臓の世界市場2023-2030
出版日: 2023年05月22日
発行: Orion Market Research
ページ情報: 英文 145 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

人工腎臓の世界市場は、予測期間中にCAGR 13.0%の大幅な成長が見込まれています。市場成長の要因は、後天性嚢胞性腎臓病、糸球体疾患、糖尿病、その他などの疾患を患う患者が世界的に増加していることです。さらに、腎臓ドナーが少ないことも市場成長を強める重要な要因です。例えば、米国疾病予防管理センター(CDC)によると、2021年には米国成人の7人に1人、つまり15%、3,700万人以上が慢性腎臓病(CKD)と診断されます。

革新的な人工腎臓を製造するための研究開発活動の増加は、人工腎臓市場の成長をさらに後押しすると予想されます。例えば、2021年6月、UCLA Healthは「開発中の人工腎臓は透析のない生活を提供することを目指す」という記事を発表しました。この記事によると、米国保健福祉省(HHS)は腎臓病の予防、診断、治療におけるイノベーションを加速するために米国腎臓学会(ASN)と提携しました。現在、両組織は水を使わない透析液フリー技術の開発に共同で取り組んでおり、2026年までに初の移植可能な人工腎臓の開発を支援しています。

セグメント別展望

血液透析サブセグメントが人工腎臓の世界市場で大きなシェアを占める

透析タイプ別では、血液透析が世界の人工腎臓市場で大きなシェアを占めると予想されています。血液透析は、血液中の老廃物や水分をろ過する治療法です。血圧(BP)をコントロールし、血液中のカリウム、ナトリウム、カルシウムなどの重要なミネラルのバランスをとるのに役立ちます。同分野の成長は、世界人口の糖尿病や高血圧の増加とともに、末期腎疾患(ESRD)の増加によるものです。米国国立衛生研究所(NIH)によると、2021年には米国で約78万6,000人がESRDを患っています。そのうち71%が透析を受け、29%が腎移植を選ぶと予想されています。

地域別展望

アジア太平洋地域は世界の人工腎臓市場で大きなシェアを占めると予想される

すべての地域の中で、アジア太平洋地域は予測期間中に人工腎臓市場で大きなシェアを占めると予測されています。市場成長を後押しする要因としては、慢性腎臓病に罹患する人々の増加、人工腎臓の生産能力を強化するための地域の主要市場プレイヤーによる投資の増加などが挙げられます。例えば、2020年12月、日本の医療機器メーカーであるニプロアジアは、透析装置に使用される人工腎臓の世界の生産設備を増強するために約9億5,800万米ドルを支出しました。この投資は2026年度までの予定で、主にベトナムと自国市場の工場に投入されます。総生産能力は月産1,200万ユニットに達します。この拡張は、経済成長に伴い糖尿病患者が増加している新興国でのダイアライザーの販売を強化するニプロの計画をサポートします。

目次

第1章 レポート概要

業界の現状分析と成長ポテンシャルの展望

  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Cardinal Health
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Medtronics plc
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Siemens Medical Solutions USA Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 人工腎臓の世界市場:デバイスタイプ別
    • ウェアラブル人工腎臓
    • 埋め込み型人工腎臓
  • 人工腎臓の世界市場:透析タイプ別
    • 血液透析
    • 腹膜透析

人工腎臓の世界市場:エンドユーザー別

透析センター

    • 専門クリニック
    • 病院

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • Asahi Kasei Corp.
  • AWAK Technologies
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • DaVita Inc.
  • Dynarex Corp.
  • Fresenius Medical Care AG & Co.
  • Kawasumi Laboratories, Inc.
  • Medline Industries, LP.
  • Merit Medical Systems.
  • Nanodialysis
  • Nikkiso Co., Ltd.
  • Organ Recovery Systems
  • Transonic
  • Triomed AB
図表

LIST OF TABLES

  • 1.GLOBAL ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022-2030 ($ MILLION)
  • 2.GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3.GLOBAL IMPLANTABLE ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4.GLOBAL ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY DIALYSIS TYPE, 2022-2030 ($ MILLION)
  • 5.GLOBAL ARTIFICIAL KIDNEY FOR HEMODIALYSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6.GLOBAL ARTIFICIAL KIDNEY FOR PERITONEAL DIALYSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)

GLOBAL ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

  • 8.GLOBAL ARTIFICIAL KIDNEY IN DIALYSIS CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9.GLOBAL ARTIFICIAL KIDNEY IN SPECIALTY CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10.GLOBAL ARTIFICIAL KIDNEY IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11.GLOBAL ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12.NORTH AMERICAN ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 13.NORTH AMERICAN ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022-2030 ($ MILLION)
  • 14.NORTH AMERICAN ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY DIALYSIS TYPE, 2022-2030 ($ MILLION)

NORTH AMERICAN ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

  • 16.EUROPEAN ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 17.EUROPEAN ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022-2030 ($ MILLION)
  • 18.EUROPEAN ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY DIALYSIS TYPE, 2022-2030 ($ MILLION)

EUROPEAN ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

  • 20.ASIA-PACIFIC ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 21.ASIA-PACIFIC ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022-2030 ($ MILLION)
  • 22.ASIA-PACIFIC ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY DIALYSIS TYPE, 2022-2030 ($ MILLION)

ASIA-PACIFIC ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

  • 24.REST OF THE WORLD ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 25.REST OF THE WORLD ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022-2030 ($ MILLION)
  • 26.REST OF THE WORLD ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY DIALYSIS TYPE, 2022-2030 ($ MILLION)

REST OF THE WORLD ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1.GLOBAL ARTIFICIAL KIDNEY MARKET SHARE BY DEVICE TYPE, 2022 VS 2030 (%)
  • 2.GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3.GLOBAL IMPLANTABLE ARTIFICIAL KIDNEY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4.GLOBAL ARTIFICIAL KIDNEY MARKET SHARE BY DIALYSIS TYPE, 2022 VS 2030 (%)
  • 5.GLOBAL ARTIFICIAL KIDNEY FOR HEMODIALYSIS MARKET SHARE BY REGION, 2022 VS 2030 (%)

GLOBAL ARTIFICIAL KIDNEY FOR PERITONEAL DIALYSIS MARKET SHARE BY REGION, 2022 VS 2030 (%)

  • 7.GLOBAL ARTIFICIAL KIDNEY MARKET SHARE BY END-USER, 2022 VS 2030 (%)

GLOBAL ARTIFICIAL KIDNEY IN DIALYSIS CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)

  • 9.GLOBAL ARTIFICIAL KIDNEY IN SPECIALTY CLINICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10.GLOBAL ARTIFICIAL KIDNEY IN HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030(%)
  • 11.GLOBAL ARTIFICIAL KIDNEY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12.US ARTIFICIAL KIDNEY MARKET SIZE, 2022-2030 ($ MILLION)
  • 13.CANADA ARTIFICIAL KIDNEY MARKET SIZE, 2022-2030 ($ MILLION)
  • 14.UK ARTIFICIAL KIDNEY MARKET SIZE, 2022-2030 ($ MILLION)
  • 15.FRANCE ARTIFICIAL KIDNEY MARKET SIZE, 2022-2030 ($ MILLION)
  • 16.GERMANY ARTIFICIAL KIDNEY MARKET SIZE, 2022-2030 ($ MILLION)
  • 17.ITALY ARTIFICIAL KIDNEY MARKET SIZE, 2022-2030 ($ MILLION)
  • 18.SPAIN ARTIFICIAL KIDNEY MARKET SIZE, 2022-2030 ($ MILLION)
  • 19.REST OF EUROPE ARTIFICIAL KIDNEY MARKET SIZE, 2022-2030 ($ MILLION)
  • 20.INDIA ARTIFICIAL KIDNEY MARKET SIZE, 2022-2030 ($ MILLION)
  • 21.CHINA ARTIFICIAL KIDNEY MARKET SIZE, 2022-2030 ($ MILLION)
  • 22.JAPAN ARTIFICIAL KIDNEY MARKET SIZE, 2022-2030 ($ MILLION)
  • 23.SOUTH KOREA ARTIFICIAL KIDNEY MARKET SIZE, 2022-2030 ($ MILLION)
  • 24.REST OF ASIA-PACIFIC ARTIFICIAL KIDNEY MARKET SIZE, 2022-2030 ($ MILLION)
  • 25.REST OF THE WORLD ARTIFICIAL KIDNEY MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027305

Global Artificial Kidney Market Size, Share & Trends Analysis Report by Device Type (Wearable Artificial Kidney and Implantable Artificial Kidney), by Dialysis Type (Hemodialysis and Peritoneal Dialysis), and by End-User (Dialysis Centers, Specialty Clinics, and Hospitals) Forecast Period (2023-2030)

The global artificial kidney market is anticipated to grow at a considerable CAGR of 13.0% during the forecast period. The market growth is attributed to factors including the increasing number of patients suffering from diseases such as Acquired Cystic Kidney Disease, Glomerular Diseases, Diabetes Insipidus, and others, globally. Moreover, the less availability of kidney donors is another key factor intensifying the market growth. For instance, according to the Center for Disease Control and Prevention (CDC), in 2021 more than 1 in 7, that is 15% of US adults or 37 million people are diagnosed with chronic kidney disease (CKD).

The increasing R&D activities for manufacturing the innovative artificial kidney is anticipated to further bolster the growth of the artificial kidney market. For instance, in June 2021, UCLA Health published an article stating "Artificial Kidney in Development Aims to Offer Dialysis Free Life". As per the article, the US Department of Health and Human Services (HHS) partnered with the American Society of Nephrology (ASN) to accelerate innovation in the prevention, diagnosis and treatment of kidney diseases. For which, currently, both the organizations are working together to develop waterless, dialysate-free technology , supports in creating the 1st implantable artificial kidney by 2026.

Segmental Outlook

The global artificial kidney market is segmented based on its device type, dialysis type, and end-user. Based on device type, the market is bifurcated into wearable artificial kidney and implantable artificial kidney. Based on dialysis type, the market is segmented into hemodialysis and peritoneal dialysis. Further, based on the end-user, the market is sub-segmented into dialysis centers, specialty clinics, and hospitals. Among the end-user, the hospitals sub-segment is anticipated to have a significant market share owing to the expansion of kidney disease related healthcare facilities and hospitals across the globe.

Hemodialysis Sub-Segment to Hold a Major Market Share in the Global Artificial Kidney Market

Among the dialysis type segment, hemodialysis is anticipated to hold a prominent market share of the global artificial kidney market. Hemodialysis is a treatment to filter wastes and water from the blood. It helps in controlling blood pressure (BP) and balance important minerals, such as potassium, sodium, and calcium, in blood. The segmental growth is attributed to the rising number of end-stage renal diseases (ESRD) along with the increasing incidences of diabetes and hypertension among the global population. According to the National Institute of Health (NIH), around 786,000 people in the US are living with ESRD in 2021. Of which, 71% are on dialysis and 29% are expected to opt kidney transplant.

Regional Outlooks

The global artificial kidney market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these, the European region is anticipated to grow at a considerable rate in the artificial kidney market during the forecast period owing to the increasing healthcare expenditure coupled with the rising prevalence of kidney diseases. The general government health expenditure in the European Union (EU) region amounted nearly around $1.3 trillion in 2021, which is around 8% of the total gross domestic product of the region (GDP).

Global Artificial Kidney Market Growth, by Region 2023-2030

Source: OMR Analysis

The Asia-Pacific Region is Anticipated to Hold a Significant Share in the Global Artificial Kidney Market

Among all regions, the Asia-Pacific region is anticipated to account for a significant share of the artificial kidney market during the forecast period. Factors bolstering the market growth includes the increasing number of people suffering with chronic kidney diseases and increasing investment by regional key market players to enhance the production capacity of artificial kidneys. For instance, in December 2020, Japanese medical device manufacturer Nipro Asia spent around $958 million to ramp-up the global production facility of artificial kidneys used in dialysis machines. The investment, which runs through fiscal 2026, will go mainly toward factories in Vietnam and the home market. Total output capacity will reach 12 million units a month. This expansion will support Nipro's plans to boost dialyzer sales in emerging countries, where diabetes patients have increased with economic growth.

Market Players Outlook

The major companies serving the global artificial kidney market include B. Braun Melsungen AG, Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Medtronic plc, Nikkiso Co. Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2022, Medtronic plc and DaVita Inc. partnered to form a new, independent kidney care-focused medical device company NewCoto enhance the patient treatment experience and improve overall outcomes.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global artificial kidney market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1.Report Summary

Current Industry Analysis and Growth Potential Outlook

  • 1.1.Research Methods and Tools
  • 1.2.Market Breakdown
    • 1.2.1.By Segments
    • 1.2.2.By Region

2.Market Overview and Insights

  • 2.1.Scope of the Report
  • 2.2.Analyst Insight & Current Market Trends
    • 2.2.1.Key Findings
    • 2.2.2.Recommendations
    • 2.2.3.Conclusion

3.Competitive Landscape

  • 3.1.Key Company Analysis
  • 3.2.Cardinal Health
    • 3.2.1.Overview
    • 3.2.2.Financial Analysis
    • 3.2.3.SWOT Analysis
    • 3.2.4.Recent Developments
  • 3.3.Medtronics plc
    • 3.3.1.Overview
    • 3.3.2.Financial Analysis
    • 3.3.3.SWOT Analysis
    • 3.3.4.Recent Developments
  • 3.4.Siemens Medical Solutions USA Inc.
    • 3.4.1.Overview
    • 3.4.2.Financial Analysis
    • 3.4.3.SWOT Analysis
    • 3.4.4.Recent Developments
  • 3.5.Key Strategy Analysis

4.Market Segmentation

  • 4.1.Global Artificial Kidney Market by Device Type
    • 4.1.1.Wearable Artificial Kidney
    • 4.1.2.Implantable Artificial Kidney
  • 4.2.Global Artificial Kidney Market by Dialysis Type
    • 4.2.1.Hemodialysis
    • 4.2.2.Peritoneal Dialysis

Global Artificial Kidney Market by End-User

Dialysis Centers

    • 4.3.2.Specialty Clinics
    • 4.3.3.Hospitals

5.Regional Analysis

  • 5.1.North America
    • 5.1.1.United States
    • 5.1.2.Canada
  • 5.2.Europe
    • 5.2.1.UK
    • 5.2.2.Germany
    • 5.2.3.Italy
    • 5.2.4.Spain
    • 5.2.5.France
    • 5.2.6.Rest of Europe
  • 5.3.Asia-Pacific
    • 5.3.1.China
    • 5.3.2.India
    • 5.3.3.Japan
    • 5.3.4.South Korea
    • 5.3.5.Rest of Asia-Pacific
  • 5.4.Rest of the World

6.Company Profiles

  • 6.1.Asahi Kasei Corp.
  • 6.2.AWAK Technologies
  • 6.3.B. Braun Melsungen AG
  • 6.4.Baxter International, Inc.
  • 6.5.DaVita Inc.
  • 6.6.Dynarex Corp.
  • 6.7.Fresenius Medical Care AG & Co.
  • 6.8.Kawasumi Laboratories, Inc.
  • 6.9.Medline Industries, LP.
  • 6.10.Merit Medical Systems.
  • 6.11.Nanodialysis
  • 6.12.Nikkiso Co., Ltd.
  • 6.13.Organ Recovery Systems
  • 6.14.Transonic
  • 6.15.Triomed AB